Logo image of WORX

SCWORX CORP (WORX) Stock Fundamental Analysis

NASDAQ:WORX - Nasdaq - US78396V2088 - Common Stock - Currency: USD

0.4641  +0.03 (+6.44%)

After market: 0.4645 +0 (+0.09%)

Fundamental Rating

1

Taking everything into account, WORX scores 1 out of 10 in our fundamental rating. WORX was compared to 36 industry peers in the Health Care Technology industry. Both the profitability and financial health of WORX have multiple concerns. WORX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

WORX had negative earnings in the past year.
In the past year WORX has reported a negative cash flow from operations.
In the past 5 years WORX always reported negative net income.
WORX had a negative operating cash flow in each of the past 5 years.
WORX Yearly Net Income VS EBIT VS OCF VS FCFWORX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M

1.2 Ratios

With a Return On Assets value of -20.04%, WORX perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
WORX has a Return On Equity (-25.63%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -20.04%
ROE -25.63%
ROIC N/A
ROA(3y)-33.77%
ROA(5y)-42.54%
ROE(3y)-51.97%
ROE(5y)-68.9%
ROIC(3y)N/A
ROIC(5y)N/A
WORX Yearly ROA, ROE, ROICWORX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K -1K

1.3 Margins

With a Gross Margin value of 23.27%, WORX is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
WORX's Gross Margin has improved in the last couple of years.
WORX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.52%
GM growth 5Y3.43%
WORX Yearly Profit, Operating, Gross MarginsWORX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, WORX has more shares outstanding
The number of shares outstanding for WORX has been increased compared to 5 years ago.
WORX has a better debt/assets ratio than last year.
WORX Yearly Shares OutstandingWORX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
WORX Yearly Total Debt VS Total AssetsWORX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -5.83, we must say that WORX is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of WORX (-5.83) is worse than 83.33% of its industry peers.
WORX has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.00, WORX is doing good in the industry, outperforming 63.89% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.83
ROIC/WACCN/A
WACCN/A
WORX Yearly LT Debt VS Equity VS FCFWORX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 0.84 indicates that WORX may have some problems paying its short term obligations.
WORX has a Current ratio of 0.84. This is in the lower half of the industry: WORX underperforms 77.78% of its industry peers.
A Quick Ratio of 0.84 indicates that WORX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.84, WORX is doing worse than 77.78% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.84
WORX Yearly Current Assets VS Current LiabilitesWORX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

0

3. Growth

3.1 Past

WORX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 72.06%, which is quite impressive.
WORX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -20.00%.
WORX shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.64% yearly.
EPS 1Y (TTM)72.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-71.81%
Revenue 1Y (TTM)-20%
Revenue growth 3Y-13.57%
Revenue growth 5Y-11.64%
Sales Q2Q%-11.3%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WORX Yearly Revenue VS EstimatesWORX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

WORX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WORX Price Earnings VS Forward Price EarningsWORX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WORX Per share dataWORX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

WORX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SCWORX CORP

NASDAQ:WORX (7/2/2025, 7:59:32 PM)

After market: 0.4645 +0 (+0.09%)

0.4641

+0.03 (+6.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)N/A N/A
Earnings (Next)09-22 2025-09-22
Inst Owners5.22%
Inst Owner Change63.82%
Ins Owners1.81%
Ins Owner Change0%
Market Cap1.69M
Analysts0
Price TargetN/A
Short Float %2.52%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.58
P/FCF N/A
P/OCF N/A
P/B 0.3
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.89
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.39
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS0.8
BVpS1.54
TBVpS-0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.04%
ROE -25.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.27%
FCFM N/A
ROA(3y)-33.77%
ROA(5y)-42.54%
ROE(3y)-51.97%
ROE(5y)-68.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.52%
GM growth 5Y3.43%
F-Score3
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.84
Altman-Z -5.83
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)72.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-71.81%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-20%
Revenue growth 3Y-13.57%
Revenue growth 5Y-11.64%
Sales Q2Q%-11.3%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-14.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-204.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-204.13%
OCF growth 3YN/A
OCF growth 5YN/A